Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pegylated recombinant Erwinia chrysanthemi L-asparaginase

EU orphan designation number: EU/3/11/889   
Active ingredient: Pegylated recombinant Erwinia chrysanthemi L-asparaginase
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: Jazz Pharmaceuticals France SAS
City One, 84 quai Charles de Gaulle, 69006 Lyon, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/08/2011 Orphan designation EMA/OD/168/10 (2011)5814 of 05/08/2011
23/03/2012 Transfer of orphan designation EMA/OD/168/10/T/01 (2012)2020 of 21/03/2012
30/09/2016 Change of name and/or address of sponsor